10
October
The survey is available on thenextbreath.it, the Sanofi portal dedicated to severe asthma About three patients out of four with severe asthma show that the disease has a strong impact on the quality of their life: a significant fact that emerges from a research conducted by Doxa Pharma for Sanofi. This is the first specific survey on patients with severe asthma, of which [...]
read more